Finally, inhibitors of the PLA2G4A which have been pursued and brought into clinical development for treating inflammatory diseases may prove useful as antiviral therapeutics for the treatment of chronic HCV infection and possibly other viral diseases. The gene discussed is PLA2G4A; the disease is viral infectious disease.